Market cap
$33 Mln
Revenue (TTM)
$11 Mln
P/E Ratio
13.2
P/B Ratio
2.8
Div. Yield
5.7 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
0.2 %
-
ROCE
-- %
-
Industry P/E
37.91
-
EV/EBITDA
9.3
-
Debt to Equity
0
-
Book Value
$2.5
-
EPS
$0.5
-
Face value
--
-
Shares outstanding
4,594,319
10 Years Aggregate
CFO
$39.97 Mln
EBITDA
$46.39 Mln
Net Profit
$37.31 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
United-Guardian (UG)
| 15.8 | 0.2 | 2.1 | -17.9 | -3.7 | -14.4 | -7.2 |
|
BSE Sensex*
| -10.2 | -3.7 | 2.5 | -5.8 | 4.9 | 5.5 | 10.1 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
United-Guardian (UG)
| -35.6 | 32.5 | -31.0 | -36.5 | 17.6 | -23.3 | 13.2 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
United-Guardian (UG)
|
7.1 | 32.8 | 11.2 | 2.5 | 16.5 | 21.6 | 13.2 | 2.8 |
| 17.4 | 6,074.3 | 3,117.6 | 157.4 | 14.7 | -- | 36.3 | 188.5 | |
| 206.7 | 10,826.1 | 776.6 | -191.6 | -17.6 | -223.4 | -- | 131.0 | |
| 74.8 | 14,630.7 | 691.8 | -696.2 | -89.1 | -- | -- | 123.7 | |
| 111.6 | 12,065.9 | 830.8 | 54.9 | 3.2 | 8.1 | 248 | 17.3 | |
| 12.0 | 10,020.9 | 332,834.2 | 33,166.6 | 11.1 | 8.9 | 29.3 | 2.5 | |
| 24.5 | 12,236.5 | 5,020.0 | -199.0 | 1.6 | -3 | -- | 1.9 | |
| 285.6 | 5,693.6 | 290.5 | 197.2 | 82.5 | 19.9 | 29.8 | 5.9 | |
| 68.7 | 6,145.7 | 450.9 | 138.6 | 39.1 | 115.6 | 49 | 30.7 | |
| 124.7 | 8,210.6 | 431.8 | -136.7 | -30.8 | -30.3 | -- | 19.0 |
Shareholding Pattern
View DetailsAbout United-Guardian (UG)
United-Guardian, Inc. develops, manufactures, sells, and markets specialty cosmetic ingredients, pharmaceutical products, medical lubricants, and sexual wellness ingredients in the United States and internationally. The company offers cosmetic... ingredients, including LUBRAJEL, a line of multifunctional hydrogel formulations for personal care and medical products; B-122, a powdered lubricant used in the manufacture of certain cosmetics, such as pressed powders, eyeliners, and rouges, as well as some industrial products; ORCHID COMPLEX, an oil-based extract of orchids; and LUBRASIL II SB, a special formulation of Lubrajel in which silicone oil incorporates into a Lubrajel base. It also provides medical lubricant products for catheter lubrication, medical devices, condom lubrication, and oral care under the Lubrajel brand, including Lubrajel MG, Lubrajel MGL, Lubrajel RRCG, Lubrajel RR, Lubrajel RC, Lubrajel RA, Lubrajel Fluid, Lubrajel LC, Lubrajel BA, and Lubrajel FACO. In addition, the company offers pharmaceutical products comprising RENACIDIN, a prescription to prevent and to dissolve calcifications in urethral catheters; and CLORPACTIN WCS-90, a chlorine-based drug, which is a topical antimicrobial and is also used in urology. Further, it provides sexual wellness ingredient products, which are hydrogel formulations designed to offer sensory enhancement, lubrication, and moisturization, such as Natrajel NT, Natrajel MA, Natrajel ON, and Natrajel TE product lines. United-Guardian, Inc. was founded in 1942 and is based in Hauppauge, New York. Read more
-
President
Ms. Donna Vigilante
-
President
Ms. Donna Vigilante
-
Headquarters
Hauppauge, NY
-
Website
FAQs for United-Guardian (UG)
What is the current share price of United-Guardian Inc (UG) Today?
The share price of United-Guardian Inc (UG) is $7.14 (NASDAQ) as of 04-Sep-2026 16:00 EDT. United-Guardian Inc (UG) has given a return of -3.74% in the last 3 years.
What is the current PB & PE ratio of United-Guardian Inc (UG)?
The P/E ratio of United-Guardian Inc (UG) is 13.21 times as on 04-Sep-2026, a 65 discount to its peers’ median range of 37.91 times.
The P/B ratio of United-Guardian Inc (UG) is 2.79 times as on 04-Sep-2026, a 64 discount to its peers’ median range of 7.69 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
13.44 |
2.52 |
2024 |
13.51 |
3.70 |
2023 |
12.81 |
2.90 |
2022 |
18.67 |
5.18 |
2021 |
16.22 |
7.70 |
What is the 52 Week High and Low of United-Guardian Inc (UG)?
The 52-week high and low of United-Guardian Inc (UG) are Rs 8.69 and Rs 5.58 as of 07-Sep-2026.
What is the market cap of United-Guardian Inc (UG)?
United-Guardian Inc (UG) has a market capitalisation of $ 33 Mln as on 04-Sep-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in United-Guardian Inc (UG)?
Before investing in United-Guardian Inc (UG), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.